Cantor Fitzgerald initiated coverage of BridgeBio Oncology (BBOT) with an Overweight rating.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential